Nirvana Life Sciences Inc. (CSE:NIRV)
0.1000
+0.0700 (233.33%)
Mar 26, 2025, 1:45 PM EST
Nirvana Life Sciences Statistics
Total Valuation
CSE:NIRV has a market cap or net worth of CAD 1.45 million. The enterprise value is 1.54 million.
Market Cap | 1.45M |
Enterprise Value | 1.54M |
Important Dates
The next estimated earnings date is Thursday, April 3, 2025.
Earnings Date | Apr 3, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:NIRV has 4.82 million shares outstanding. The number of shares has increased by 4.54% in one year.
Current Share Class | n/a |
Shares Outstanding | 4.82M |
Shares Change (YoY) | +4.54% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 18.09% |
Owned by Institutions (%) | n/a |
Float | 3.59M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.83 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
Current Ratio | 0.02 |
Quick Ratio | 0.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -200.02% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 28.40% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.33% in the last 52 weeks. The beta is 0.85, so CSE:NIRV's price volatility has been lower than the market average.
Beta (5Y) | 0.85 |
52-Week Price Change | -83.33% |
50-Day Moving Average | 0.28 |
200-Day Moving Average | 0.45 |
Relative Strength Index (RSI) | 72.08 |
Average Volume (20 Days) | 1,281 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -371,556 |
Pretax Income | -544,719 |
Net Income | -543,698 |
EBITDA | -351,715 |
EBIT | -371,556 |
Earnings Per Share (EPS) | -0.12 |
Balance Sheet
The company has 638 in cash and 97,226 in debt, giving a net cash position of -96,588 or -0.02 per share.
Cash & Cash Equivalents | 638 |
Total Debt | 97,226 |
Net Cash | -96,588 |
Net Cash Per Share | -0.02 |
Equity (Book Value) | -1.33M |
Book Value Per Share | -0.28 |
Working Capital | -1.31M |
Cash Flow
Operating Cash Flow | -49,749 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:NIRV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.54% |
Shareholder Yield | -4.54% |
Earnings Yield | -37.57% |
FCF Yield | n/a |
Stock Splits
The last stock split was on March 24, 2025. It was a reverse split with a ratio of 0.1.
Last Split Date | Mar 24, 2025 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |